Obviousness

Based on a thorough review of the specification of U.S. Patent No. 11,974,910, several of its key inventive concepts appear to be obvious in light of prior art existing before the patent's priority date of August 13, 2018. The analysis below presents potential invalidity arguments under 35 U.S.C. § 103 for the core aspects of the described technology.

A person of ordinary skill in the art (POSA) at the time of this invention would have been a medical device engineer or interventional radiologist/cardiologist with several years of experience in developing or using endovascular devices for treating thromboembolic disease. Such a person would have been familiar with catheter-based aspiration systems, the principles of fluid dynamics, and the challenges associated with removing organized thrombus from blood vessels.

Analysis of Key Concepts

The patent describes several systems and methods for emboli treatment. The primary inventive concepts appear to be:

1. A system for aspirating a clot by first creating a vacuum in a pressure source (e.g., a large syringe) while it is isolated from the catheter by a valve, and then rapidly opening the valve to apply the stored vacuum to the catheter, creating a powerful, instantaneous suction.
2. A system utilizing two nested catheters, where a larger guide catheter is positioned proximally to a clot, and a smaller catheter is advanced through it to the clot site for aspiration.
3. A system incorporating an in-line filter to separate aspirated clot material from blood, allowing for the potential reinfusion of the filtered blood.

These concepts, when broken down into their constituent elements, are arguably obvious combinations of pre-existing technologies.

---

Obviousness Ground 1: The "Stored Vacuum" Aspiration System

Claimed Invention (based on FIGS. 1-3 and accompanying text): A system comprising an aspiration catheter, a pressure source (like a large-bore syringe), and a fluid control device (like a stopcock). The method involves closing the control device, pulling back the syringe plunger to create and store a vacuum, and then opening the control device to apply this pre-charged vacuum to the catheter for clot aspiration. The stated advantage is creating a more powerful, rapid suction force compared to conventional aspiration.

Prior Art Combination:

• Primary Reference: A standard thrombectomy aspiration catheter system, such as those described in various prior art patents (e.g., U.S. Patent 6,010,496 to Sinanan or U.S. Patent 8,986,323 to Belson), which teach the use of a catheter connected to a syringe for aspirating embolic material. These systems establish the fundamental components: a catheter for reaching the thrombus and a syringe for applying negative pressure.
• Secondary Reference: General principles of fluid dynamics and vacuum systems, which are matters of common knowledge in physics and engineering. The concept that releasing a stored vacuum into a closed system creates a more rapid and forceful fluid movement than gradually generating a vacuum is a fundamental principle. This principle is widely applied in various fields, such as in industrial vacuum systems for material handling or cleaning.

Motivation to Combine & Rationale for Obviousness:

A person of ordinary skill in the art (POSA) would have been well aware of the challenges in removing adherent, organized, or "sticky" thrombus. A common problem is that the steady, low-flow suction generated by simply pulling back on a syringe plunger may be insufficient to dislodge the clot from the vessel wall.

The POSA, seeking to increase the initial "pulling power" of the aspiration system, would have been motivated to find ways to maximize the initial pressure differential and flow rate at the catheter tip. The idea of "priming" or "charging" a vacuum source and then releasing it suddenly is a well-understood method for generating a high-impulse force. It would have been an obvious and logical step to apply this basic physical principle to the known medical aspiration system.

A POSA would understand that by isolating the syringe with a stopcock, pulling the plunger to create a vacuum, and then rapidly opening the stopcock, the pressure gradient between the pre-evacuated syringe and the blood-filled catheter would equalize much faster. This rapid equalization would generate a momentary high-velocity inrush of fluid (blood and clot) into the catheter, providing the desired increase in dislodgement force. This combination of a standard aspiration catheter with the principle of stored vacuum would have been obvious to try with a reasonable expectation of success for removing more tenacious clots. The patent's focus on large-bore syringes and connectors (e.g., the Toomey tip syringe in FIG. 3A) is merely an obvious design choice to minimize flow resistance, a standard engineering consideration when trying to maximize flow rate.

---

Obviousness Ground 2: The Telescoping Catheter Aspiration System

Claimed Invention (based on FIGS. 11-14 and accompanying text): A method involving a first, larger guide catheter and a second, smaller aspiration catheter. The first catheter is positioned in a larger, more proximal vessel, and the second catheter is advanced through the first to reach a smaller, more distal vessel where the clot is located. Aspiration is then performed through the second catheter. The system may also use the first catheter to aspirate any clot material that trails from the second catheter during its withdrawal.

Prior Art Combination:

• Primary Reference: Any standard "guide catheter" or "mother-and-child" catheter system used in interventional procedures. For example, U.S. Patent 5,690,642 to Lary discloses a system of telescoping catheters for delivering agents or devices to remote vascular locations. The technique of using a larger, more supportive catheter to provide a conduit for a smaller, more flexible catheter to reach distal or tortuous anatomy was well-established in interventional cardiology and radiology long before 2018.
• Secondary Reference: A standard aspiration thrombectomy system as described above (e.g., Sinanan or Belson), which teaches the principle of using a catheter connected to a suction source to remove a clot.

Motivation to Combine & Rationale for Obviousness:

A POSA would often face the clinical challenge of a pulmonary embolism or deep vein thrombosis that extends into smaller, branching vessels. A large-bore aspiration catheter, while effective at removing bulk clot, might be too large and stiff to navigate into these distal areas.

Confronted with this problem, the POSA would naturally turn to established solutions for accessing such anatomy. The use of telescoping catheters (as taught by Lary and common in practice) is the standard and obvious solution to this very problem. A POSA would have been motivated to combine the aspiration functionality of a thrombectomy catheter with the access technique of a telescoping system.

It would have been a matter of routine design to select a large guide catheter (the "first catheter") and a smaller aspiration catheter (the "second catheter") with compatible diameters. The method of advancing the guide catheter to the main vessel and then tracking the smaller aspiration catheter through it to the target clot is a direct application of a known technique for a predictable purpose. The additional step of aspirating through the guide catheter during withdrawal to "clean up" any trailing debris is also an obvious precautionary measure to prevent distal embolization, a well-known concern in all thrombectomy procedures.

---

Obviousness Ground 3: The Aspiration System with Blood Filtration and Reinfusion

Claimed Invention (based on FIGS. 19-23 and accompanying text): An aspiration system that includes a filter canister placed in-line between the catheter and the suction syringe. This filter is designed to capture the aspirated clot material while allowing blood to pass through and collect in the syringe. The filtered blood can then be returned to the patient.

Prior Art Combination:

• Primary Reference: An aspiration thrombectomy system, such as Penumbra, Inc.'s Indigo® Aspiration System (commercially available before 2018), which uses a pump and a collection canister to aspirate blood and clot. These systems inherently involve the collection of blood along with the clot.
• Secondary Reference: The concept of intraoperative blood salvage or "cell saver" systems, which have been in use for decades. These systems collect blood lost during surgery, filter it to remove clots and tissue debris, and re-infuse it to the patient. U.S. Patent 4,770,781 to Ghee, for example, describes a blood recovery and filtration system for this purpose.

Motivation to Combine & Rationale for Obviousness:

One of the primary risks associated with large-volume aspiration thrombectomy is iatrogenic blood loss. A POSA would recognize that aspirating a large clot burden from a major vessel like the pulmonary artery would necessarily involve aspirating a significant volume of the patient's blood. Minimizing blood loss is a constant goal in any surgical or interventional procedure.

The POSA, facing the problem of blood loss during aspiration thrombectomy, would logically look to the established field of autotransfusion and blood salvage for a solution. The concept of filtering blood to remove unwanted material and then returning it to the patient is the central principle of this field. It would have been obvious to apply this principle to the blood being aspirated by a thrombectomy catheter.

Combining the two would involve placing a filter, analogous to those described by Ghee or used in cell saver systems, in-line with the aspiration circuit. A POSA would have a reasonable expectation of success that such a filter could separate the solid clot fragments from the liquid blood, which could then be collected and reinfused. The specific design of the filter canister in the '910 patent represents routine engineering and optimization, not an inventive leap over the fundamental and obvious concept of combining aspiration with filtration for blood conservation.